Gary Holland to AIDS-Related Opportunistic Infections
This is a "connection" page, showing publications Gary Holland has written about AIDS-Related Opportunistic Infections.
Connection Strength
4.239
-
Characteristics of untreated AIDS-related cytomegalovirus retinitis. I. Findings before the era of highly active antiretroviral therapy (1988 to 1994). Am J Ophthalmol. 2008 Jan; 145(1):5-11.
Score: 0.269
-
Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008 Jan; 145(1):12-22.
Score: 0.269
-
Argon laser demarcation of AIDS-related cytomegalovirus retinitis in resource-limited setting. Int Ophthalmol. 2026 Mar 19; 46(1).
Score: 0.238
-
Clear lens extraction with intraocular lens implantation during retinal detachment repair in patients with Acquired Immune Deficiency Syndrome (AIDS) [correction of autoimmune deficiency syndrome] and cytomegalovirus retinitis. Ophthalmology. 2002 Apr; 109(4):666-73.
Score: 0.181
-
Immune recovery uveitis. Am J Ophthalmol. 2000 Jul; 130(1):103-6.
Score: 0.160
-
New issues in the management of patients with AIDS-related cytomegalovirus retinitis. Arch Ophthalmol. 2000 May; 118(5):704-6.
Score: 0.158
-
Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir. Ocul Immunol Inflamm. 2021 Aug 18; 29(6):1145-1150.
Score: 0.158
-
Treatment options for cytomegalovirus retinitis: a time for reassessment. Arch Ophthalmol. 1999 Nov; 117(11):1549-50.
Score: 0.153
-
Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
Score: 0.147
-
Therapeutic decisions: informed choices in a changing clinical environment. Am J Ophthalmol. 1999 Mar; 127(3):327-8.
Score: 0.146
-
Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1999 Jan; 106(1):133-41.
Score: 0.144
-
Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019 02; 103(2):157-160.
Score: 0.141
-
Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. Am J Ophthalmol. 2017 Feb; 174:23-32.
Score: 0.124
-
Endogenous bacterial endophthalmitis as a complication of intravenous therapy for cytomegalovirus retinopathy. Arch Ophthalmol. 1996 Jul; 114(7):879-80.
Score: 0.121
-
Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare. Br J Ophthalmol. 2016 08; 100(8):1017-21.
Score: 0.121
-
New therapies for cytomegalovirus retinitis. N Engl J Med. 1995 Sep 07; 333(10):658-9.
Score: 0.115
-
Local therapy for cytomegalovirus retinopathy. Am J Ophthalmol. 1995 Sep; 120(3):376-85.
Score: 0.115
-
Dose-related difference in progression rates of cytomegalovirus retinopathy during foscarnet maintenance therapy. AIDS Clinical Trials Group Protocol 915 Team. Am J Ophthalmol. 1995 May; 119(5):576-86.
Score: 0.112
-
Telemedicine screening for cytomegalovirus retinitis at the point of care for human immunodeficiency virus infection. JAMA Ophthalmol. 2015 Feb; 133(2):198-205.
Score: 0.110
-
Retinal detachment associated with AIDS-related cytomegalovirus retinitis: risk factors in a resource-limited setting. Am J Ophthalmol. 2015 Jan; 159(1):185-92.
Score: 0.108
-
The progressive outer retinal necrosis syndrome. Int Ophthalmol. 1994; 18(3):163-5.
Score: 0.102
-
A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS. J Infect Dis. 1993 Aug; 168(2):444-8.
Score: 0.099
-
Burden of HIV-related cytomegalovirus retinitis in resource-limited settings: a systematic review. Clin Infect Dis. 2013 Nov; 57(9):1351-61.
Score: 0.099
-
Human immunodeficiency virus and opportunistic ocular infections. Infect Dis Clin North Am. 1992 Dec; 6(4):909-23.
Score: 0.095
-
Progression rates of cytomegalovirus retinopathy in ganciclovir-treated and untreated patients. Arch Ophthalmol. 1992 Oct; 110(10):1435-42.
Score: 0.094
-
Clinical features of newly diagnosed cytomegalovirus retinitis in northern Thailand. Am J Ophthalmol. 2012 May; 153(5):923-931.e1.
Score: 0.089
-
Outcomes associated with ganciclovir implants in patients with AIDS-related cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):683.e1-8.
Score: 0.060
-
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
Score: 0.060
-
Clinician versus reading center assessment of cytomegalovirus retinitis lesion size. Ophthalmology. 2005 Apr; 112(4):559-66.
Score: 0.056
-
Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis. 2001 May 01; 183(9):1399-404.
Score: 0.042
-
Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Studies of Ocular Complications of AIDS Research Group. Arch Ophthalmol. 2000 Sep; 118(9):1196-204.
Score: 0.041
-
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
Score: 0.035
-
Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Apr 01; 17(4):339-44.
Score: 0.034
-
Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar; 125(3):292-300.
Score: 0.034
-
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis. 1998 Jan; 177(1):48-56.
Score: 0.034
-
Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial. Ann Intern Med. 1997 Feb 15; 126(4):257-63.
Score: 0.032
-
Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol. 1996 Jul; 114(7):873-7.
Score: 0.030
-
The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 1994 Sep; 101(9):1488-502.
Score: 0.027
-
Telemedicine diagnosis of cytomegalovirus retinitis by nonophthalmologists. JAMA Ophthalmol. 2014 Sep; 132(9):1052-8.
Score: 0.027
-
Combination of ganciclovir and granulocyte-macrophage colony-stimulating factor in the treatment of cytomegalovirus retinitis in AIDS patients. The ACTG 073 Team. Eur J Clin Microbiol Infect Dis. 1994; 13 Suppl 2:S34-40.
Score: 0.026
-
Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1993 Jul 15; 116(1):42-50.
Score: 0.025
-
Vitrectomy and silicone oil tamponade for cidofovir-associated hypotony with ciliary body detachment. Retina. 1999; 19(1):75-6.
Score: 0.009